How Syngene helped develop the world’s first drug for a rare disease affecting children
Learn how Syngene partnered with a U.S.-based biotech company to develop and manufacture a first-in-class treatment for a rare disease affecting children.
Accelerating PROTAC programs to drug the “undruggable”
Syngene offers expertise in all aspects of PROTACs – from designing of small molecules to their synthesis, lead optimization, and ultimate candidate delivery at an accelerated pace.
How Syngene helped Panbela achieve shorter production time for its pancreatic cancer drug
Learn how Syngene streamlined the production process of Panbela’s pancreatic cancer drug, SBP-101, while ensuring high chiral purity of 98% during GMP manufacturing
Chemistry process research lab for Drug Discovery
Syngene’s Chemistry process research lab acts as a bridge between drug discovery and development when faster delivery of chemical compounds is required – mg to kg.
Safety Assessment services
Syngene offers the full range of IND-enabling Exploratory and GLP Tox studies for small molecules and biologics.
Driving operational excellence with SQDECC
SQDECC is an industry-recognized model that enables the operational teams to get a unified view of their efficiency across parameters of Safety, Quality, Delivery, Engagement, Cost, and Compliance (SQDECC).
Achieving Biologics manufacturing milestones using a systemic approach to Technology Transfer
Learn how Syngene achieves manufacturing milestones in Biologics using a systemic approach to 100% ‘first-time right’ technology transfer.
How Organocatalysis discovered by Nobel laureates revolutionised drug development and production in Syngene
David Macmillan and Benjamin List are joint Nobel prize winners for 2021 in chemistry for their ground-breaking work on the development of asymmetric organocatalysis. The efficacy of organocatalysis in asymmetric synthesis has influenced the field of organic synthesis since the early 2000s. Recognising this powerful science, the Discovery Chemistry team at Syngene has transitioned from […]
In silico toxicity prediction using Derek Nexus for predicting skin sensitization, phototoxicity, hepatotoxicity and in vitro hERG inhib
In silico toxicity evaluation using Derek® Nexus for quicker and cost-effective screening for skin sensitization phototoxicity, hepatotoxicity, and in vitro hERG channel inhibition
Chromatography based purification of retro virus spikes
Presenting the data for purification of Retro virus using ion exchange chromatography where the condition for purification was optimized.
